[Therapy of breast cancer--change from radical to quality-controlled individualized treatment].
The treatment of breast cancer is changing continually. Thus, sentinel lymph node dissection is considered today as standard in the therapy of small unifocal breast carcinoma with clinically negative axillary lymph nodes. Concerning adjuvant therapy, the 9th Early Adjuvant Breast Cancer Meeting, along with a consensus conference, took place in Saint Gall on January 26-29, 2005. The publication of the corresponding congress report is expected for early summer of 2005.
Fink
D
D
Klinik für Gynäkologie, Departement für Frauenheilkunde, Universitätsspital, Frauenklinikstrasse 10, CH-8091 Zürich, Schweiz. daniel.fink@usz.ch
Kimmig
R
R
Winter
R
R
D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy / Q000639:trends; D003245:Consensus Statements as Topic; D005260:Female; D006801:Humans; D008197:Lymph Node Excision / Q000639:trends*; D009367:Neoplasm Staging; D011785:Quality Assurance, Health Care / Q000639:trends*; D013557:Switzerland